Regarding nuclear staining, a significant decrease in staining intensity in the post-therapeutic tumour specimen was found in the group with TRG2 (p = 0.007), TRG3 (p = 0.015) and in the control group not treated by chemotherapy (p = 0.016). The gene discussed is SAMM50; the disease is neoplasm.